Cibisatamab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cibisatamab, covering 2024-08-09 to 2025-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment [Phase 1]